D-0366-2024 Class II Ongoing

Recalled by Eugia US LLC — East Windsor, NJ

FDA drug recall D-0366-2024 was initiated by Eugia US LLC on Feb 20, 2024 and is designated Class II. Reason for recall: Failed Dissolution Specifications The recall status is ongoing. Affected quantity: 10,080 vials.

Recall details

Product Type
Drugs
Report Date
Mar 13, 2024
Initiation Date
Feb 20, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
10,080 vials

Product description

Methylprednisolone acetate Injectable Suspension, USP, 400mg per 5mL (80mg/mL, 5mL Multiple-Dose Vial, Rx only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, NDC 55150-314-01

Reason for recall

Failed Dissolution Specifications

Distribution pattern

OH, TN, LA, MS

Code information

Lot #: 3MA23001, 3MA23002, 3MA23003, Exp 3/31/2025

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0366-2024
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0366-2024. Report a data issue: hello@regdatalab.com.